Citation: Lf. Garnier, ASPIRIN IN SECONDARY CARDIOVASCULAR PREVE NTION - FROM CLINICAL-STUDIES TO DAILY PRACTICE, Annales de cardiologie et d'angeiologie, 46(8), 1997, pp. 507-512
Authors:
MAISONBLANCHE P
BREMBILLAPERROT B
FAUCHIER JP
BABUTY D
GARNIER LF
ROUESNEL P
BREUILLAC JC
FUNCK F
SCHECK F
PERAUDEAU P
MEDVEDOWSKY JL
Citation: P. Maisonblanche et al., COMPARATIVE-STUDY OF ORAL TREATMENT WITH CIBENZOLINE AND FLECAINIDE IN THE SECONDARY PREVENTION OF PAROXYSMAL ATRIAL TACHYARRHYTHMIAS, Annales de cardiologie et d'angeiologie, 46(2), 1997, pp. 109-116
Authors:
MATHIEU P
VILLEMOT JP
STOLTZ JF
SCHECK F
GARNIER LF
Citation: P. Mathieu et al., ANTIAGGREGANT EFFECT AND TOLERABILITY OF CALCIUM CARBASALATE ADMINISTERED IMMEDIATELY AFTER AORTOCORONARY BYPASS - RESULTS OF A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Pathologie et biologie, 44(6), 1996, pp. 571-580
Authors:
FAUCHIER JP
ROUESNEL P
BREUILLAC JC
COSNAY P
SCHECK F
GARNIER LF
Citation: Jp. Fauchier et al., TRIAL OF CIBENZOLINE (ORAL AND BY INJECTI ON) IN THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIAS LINKED TO INTRANODAL REENTRY OR TO AN ACCESSORY ATRIOVENTRICULAR-CONDUCTION PATHWAY, Annales de cardiologie et d'angeiologie, 43(4), 1994, pp. 194-203
Authors:
MEDVEDOWSKY JL
BINESCHECK F
DAMBRINE P
DOMEREGO JJ
GARNIER LF
LABAKI F
PIECHACZYK P
ROUESNEL P
SCHENOWITZ A
Citation: Jl. Medvedowsky et al., STUDY OF THE EFFICACY AND SAFETY OF ORAL CIBENZOLINE IN THE PREVENTION OF RECURRENCES OF SYMPTOMATIC ATRIAL-FIBRILLATION, Annales de cardiologie et d'angeiologie, 43(2), 1994, pp. 89-96
Citation: Lf. Garnier, ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND VASCULAR REMODELING IN HYPERTENSION, Annales de cardiologie et d'angeiologie, 42(8), 1993, pp. 438-444